首页> 外文期刊>Peptides: An International Journal >Cholecystokinin-33 inhibits meal size and prolongs the subsequent intermeal interval.
【24h】

Cholecystokinin-33 inhibits meal size and prolongs the subsequent intermeal interval.

机译:胆囊收缩素-33抑制进餐量并延长随后的用餐间隔。

获取原文
获取原文并翻译 | 示例
       

摘要

There are various forms of the satiety gut-brain peptide cholecystokinin (CCK), a short, widely utilized form or CCK-8, and a long, putatively more effective form or CCK-33. The issue of which of these forms is a more effective satiety peptide is not resolved. Here, we compared the satiety responses, including the sizes of the first three meals (MS) and intermeal intervals (IMI) as well as their calculated satiety ratios (SR), evoked by both peptides. CCK-8 and 33 (1, 3 and 5 nmol/kg, i.p) reduced the size of the first meal similarly, only CCK-33 prolonged the first IMI and increased SR and both peptides failed to affect second and third MS and IMI. As such, CCK-33 is a more effective satiety peptide than CCK-8. The current results confirm previous findings which showed that both peptides reduce food intake by inhibiting meal size, whereas only CCK-33 reduces food intake by prolonging the intermeal interval.
机译:饱腹性肠肽胆囊收缩素(CCK)有多种形式,一种短的,广泛使用的形式或CCK-8,和一种长的,更有效的形式或CCK-33。这些形式中的哪一种是更有效的饱腹感肽的问题尚未解决。在这里,我们比较了饱腹感响应,包括前两个进餐量(MS)和进餐间隔(IMI)以及它们由两种肽引起的饱腹率(SR)。 CCK-8和33(1、3和5 nmol / kg,i.p)相似地减少了第一顿饭的大小,只有CCK-33延长了第一顿IMI并增加了SR,并且两种肽均无法影响第二道和第三道MS和IMI。因此,CCK-33是比CCK-8更有效的饱腹感肽。目前的结果证实了先前的发现,该发现表明这两种肽均通过抑制进餐量来减少食物摄入,而只有CCK-33通过延长进食间隔来减少食物摄入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号